Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 9 July 1999: Vol. 285. no. 5425, pp. 248 - 251 DOI: 10.1126/science.285.5425.248
|
|
Reports
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Haichao Wang,
13*
Ona Bloom,
3
Minghuang Zhang,
3
Jaideep M. Vishnubhakat,
3
Michael Ombrellino,
23
Jiantu Che,
3
Asia Frazier,
23
Huan Yang,
3
Svetlana Ivanova,
3
Lyudmila Borovikova,
3
Kirk R. Manogue,
3
Eugen Faist,
4
Edward Abraham,
5
Jan Andersson,
6
Ulf Andersson,
7
Patricia E. Molina,
2
Naji N. Abumrad,
2
Andrew Sama,
1
Kevin J. Tracey
23
Endotoxin, a constituent of Gram-negative bacteria, stimulates
macrophages to release large quantities of tumor necrosis factor (TNF) and interleukin-1 (IL-1), which can precipitate tissue
injury and lethal shock (endotoxemia). Antagonists of TNF and IL-1 have shown limited efficacy in clinical trials, possibly because these cytokines are early mediators in pathogenesis. Here a potential late
mediator of lethality is identified and characterized in a mouse model.
High mobility group-1 (HMG-1) protein was found to be
released by cultured macrophages more than 8 hours after stimulation
with endotoxin, TNF, or IL-1. Mice showed increased serum levels of
HMG-1 from 8 to 32 hours after endotoxin exposure. Delayed
administration of antibodies to HMG-1 attenuated endotoxin lethality in
mice, and administration of HMG-1 itself was lethal. Septic patients
who succumbed to infection had increased serum HMG-1 levels, suggesting
that this protein warrants investigation as a therapeutic target.
1 Department of Emergency Medicine and
2 Department of Surgery, North Shore University
Hospital-New York University School of Medicine, Manhasset, NY 11030, USA.
3 The Picower Institute for Medical Research,
Manhasset, NY 11030, USA.
4 Department of Surgery, Klinicum
Grosshadern, Ludwig-Maximilians University, Munich, Germany.
5 Division of Pulmonary Sciences and Critical Care Medicine,
University of Colorado Health Sciences Center, Denver, CO 80262, USA.
6 Department of Infectious Disease, Karolinska Institute,
Huddinge University Hospital, Stockholm, Sweden.
7 Department of Rheumatology, Astrid Lindgren's Children's
Hospital, Karolinska Institute, Stockholm, Sweden.
*
To whom correspondence should be addressed. E-mail:
hwang{at}picower.edu
Read the Full Text
|
|